Umekita found that expression of maspin may be correlated with the aggressiveness of colorectal adenocarcinomas; its expression tends to decrease during the development of colon cancer from adenoma of early colon cancer, adenocarcinoma and then to metastatic tumor [8]. Here, SERPINB5 is linked to colorectal adenocarcinoma.